Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



MRI-Ultrasound Fusion Targeted Prostate Biopsies - Quality Control & Performance Improvement

Prostate

Prostate
N/A
Barocas, Daniel
VICCURO1680

Prospective Observational Trial of an Absorbable Hydrogel Spacer in Prostate Cancer Radiotherapy

Prostate

Prostate
N/A
Newman, Neil
VICCURO16112

Prospective Validation of Prostate Biomarkers for Repeat Biopsy: The PRIORITY Study

Prostate

Prostate
N/A
Chang, Sam
VICCURO1734

EDRN Prostate MRI Biomarker Study and Reference Set

Prostate

Prostate
N/A
Barocas, Daniel
VICCURO19112


Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing

Prostate

This registry will evaluate treatment selection for patients with newly diagnosed, localized prostate cancer following Prolaris testing. It will measure the proportion of men who initially select treatment with active surveillance, the time frame between active surveillance selection and any change in treatment, and clinical outcomes.
Prostate
N/A
Moses, Kelvin
NCT04404894
VICCURO2089

Standard Systemic Therapy with or without Definitive Treatment in Treating Participants with Metastatic Prostate Cancer

Prostate

This phase III trial studies whether the addition of definitive treatment (radiation or surgical removal) of the primary tumor to standard systemic therapy for patients with prostate cancer, may help prevent the cancer from the spreading to other parts of their body. Removing the prostate by either surgery or radiation therapy in addition to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Prostate
III
Schaffer, Kerry
NCT03678025
ECOGUROS1802

Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients with Prostate Cancer

Prostate

This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.
Prostate
II
Planz, Virginia
NCT03697148
ECOGUROEA8171

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: